Foam cell death induced by 7β-hydroxycholesterol is mediated by labile iron-driven oxidative injury: Mechanisms underlying induction of ferritin in human atheroma

Free Radical Biology and Medicine

Volumn 39, Issue 7, 2005, Pages 864-875

  Li, Wei ^a   Hellsten, Anna ^a   Xu, Li Hua ^a,b   Zhuang, Da Ming ^c   Jansson, Katarina ^a   Brunk, Ulf T ^a   Yuan, Xi Ming ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b BEIHUA UNIVERSITY   (China)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Atherosclerosis; Labile iron pool; Lysosomes; Macrophage death; Oxysterols; ROS

Indexed keywords

7 BETA HYDROXYCHOLESTEROL; APOFERRITIN; CHOLESTEROL DERIVATIVE; DEFEROXAMINE; FAT DROPLET; FERRITIN; IRON; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CELL DEATH; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; FOAM CELL; HUMAN; HUMAN CELL; MACROPHAGE FUNCTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION;

EID: 33644634175     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.05.006     Document Type: Article

References (51)

1. Hutter, R.; Valdiviezo, C.; Sauter, B. V.; Savontaus, M.; Chereshnev, I.; Carrick, F. E.; Bauriedel, G.; Luderitz, B.; Fallon, J. T.; Fuster, V.; Badimon, J. J. Caspase-3 and tissue factor expression in lipid-rich plaque macrophages. Evidence for apoptosis as link between inflammation and atherothrombosis. Circulation 109:2001-2008; 2004.
2. Björkerud, S.; Björkerud, B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am. J. Pathol. 149:367-380; 1996.
3. Kolodgie, F. D.; Narula, J.; Burke, A. P.; Haider, N.; Farb, A.; Hui-Liang, Y.; Smialek, J.; Virmani, R. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am. J. Pathol 157:1259-1268; 2000.
4. Libby, P.; Geng, Y. J.; Aikawa, M.; Schoenbeck, U.; Mach, F.; Clinton, S. K.; Sukhova, G. K.; Lee, R. T. Macrophages and atherosclerotic plaque stability. Curr. Opin. Lipidol. 7:330-335; 1996.
5. Yuan, X. M. Apoptotic macrophage-derived foam cells of human atheromas are rich in iron and ferritin, suggesting iron-catalysed reactions to be involved in apoptosis. Free Radic. Res. 30:221-231; 1999.
6. Brown, A. J.; Jessup, W. Oxysterols and atherosclerosis. Atherosclerosis 142:1-28; 1999.
7. Garcia-Cruset, S.; Carpenter, K. L.; Guardiola, F.; Stein, B. K.; Mitchinson, M. J. Oxysterol profiles of normal human arteries, fatty streaks and advanced lesions. Free Radic. Res. 35:31-41; 2001.
8. Lizard, G.; Monier, S.; Cordelet, C.; Gesquiere, L.; Deckert, V.; Gueldry, S.; Lagrost, L.; Gambert, P. Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta- hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. Arterioscler. Thromb. Vasc. Biol. 19:1190-1200; 1999.
9. Yuan, X. M.; Li, W.; Brunk, U. T.; Dalen, H.; Chang, Y; Sevanian, A. Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic. Biol. Med. 28:208-218; 2000.
10. Colles, S. M.; Maxson, J. M.; Carlson, S. G.; Chisolm, G. M. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc. Med. 11:131-138; 2001.
11. Li, W.; Dalen, H.; Eaton, J. W.; Yuan, X.-M. Apoptotic death of inflammatory cells in human atheroma. Arterioscler. Thromb. Vasc. Biol. 21:1124-1130; 2001.
12. Salvayre, R.; Auge, N.; Benoist, H.; Negre-Salvayre, A. Oxidized low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta 1585:213-221; 2002.
13. Yuan, X. M.; Li, W.; Dalen, H.; Lotem, J.; Kama, R.; Sachs, L.; Brunk, U. T. Lysosomal destabilization in p53-induced apoptosis. Proc. Natl. Acad. Sci. USA 99:6286-6291; 2002.
14. Leist, M.; Jaattela, M. Triggering of apoptosis by cathepsins. Cell Death Differ. 8:324-326; 2001.
15. Pang, J. H.; Jiang, M. J.; Chen, Y. L.; Wang, F. W.; Wang, D. L.; Chu, S. H.; Chau, L. Y Increased ferritin gene expression in atherosclerotic lesions. J. Clin. Invest. 97:2204-2212; 1996.
16. Yuan, X. M.; Li, W; Olsson, A. G.; Brunk, U. T. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis. Atherosclerosis 124:61-73; 1996.
17. Smith, C.; Mitchinson, M. J.; Aruoma, O. I.; Halliwell, B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286:901-905; 1992.
18. Thomas, J. P.; Geiger, P. G.; Girotti, A. W Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions. J. Lipid Res. 34:479-490; 1993.
19. Li, W; Yuan, X. M.; Brunk, U. T. OxLDL-induced macrophage cytotoxicity is mediated by lysosomal rupture and modified by intralysosomal redox-active iron. Free Radic. Res. 29:389-398; 1998.
20. Stadler, N.; Lindner, R. A.; Davies, M. J. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler. Thromb. Vasc. Biol. 24:1-7; 2004.
21. Miyajima, H.; Adachi, J.; Kohno, S.; Takahashi, Y.; Ueno, Y.; Naito, T. Increased oxysterols associated with iron accumulation in the brains and visceral organs of acaeruloplasminaemia patients. OJM 94:417-422; 2001.
22. Tuomainen, T. P.; Diczfalusy, U.; Kaikkonen, J.; Nyyssonen, K.; Salonen, J. T. Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man. Free Radic. Biol. Med. 35:922-928; 2003.
23. Fonseca, A. M.; Pereira, C. F.; Porto, G.; Arosa, F. A. Red blood cells upregulate cytoprotective proteins and the labile iron pool in dividing human T cells despite a reduction in oxidative stress. Free Radic. Biol. Med. 35:1404-1416; 2003.
24. Hasegawa, H.; Suzuki, K.; Nakaji, S.; Sugawara, K. Analysis and assessment of the capacity of neutrophils to produce reactive oxygen species in a 96-well microplate format using lucigenin- and luminol-dependent chemiluminescence. J. Immunol. Methods 210:1-10; 1997.
25. Tham, E.; Wang, J.; Piehl, F.; Weber, G. Upregulation of VEGF-A without angiogenesis in a mouse model of dilated cardiomyopathy caused by mitochondrial dysfunction. J. Histochem. Cytochem. 50:935-944; 2002.
26. Sullivan, J. L. Iron and the sex difference in heart disease risk. Lancet 1:1293-1294; 1981.
27. Salonen, J. T.; Nyyssönen, K.; Loral, H.; Tuomilehto, J.; Seppanen, R.; Salonen, R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86:803-811; 1992.
28. Yuan, X. M.; Li, W The iron hypothesis of atherosclerosis and its clinical impact. Ann. Med. 35:1-15; 2003.
29. Halliwell, B.; Gutteridge, J. M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186:1-85; 1990.
30. Burkitt, M. J.; Milne, L.; Raafat, A. A simple, highly sensitive and improved method for the measurement of bleomycin-detectable iron: the 'catalytic iron index' and its value in the assessment of iron status in haemochromatosis. Clin. Sci. (Lond.) 100:239-247; 2001.
31. Halliwell, B.; Gutteridge, J. M. C. The antioxidants of human extracellular fluids. Arch. Biochem. Biophys. 280:1-8; 1990.
32. Salonen, J. T.; Tuomainen, T. P.; Salonen, R.; Lakka, T. A.; Nyyssonen, K. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. Am. J. Epidemiol. 148:445-451; 1998.
33. Ascherio, A.; Rimm, E. B.; Giovannucci, E.; Willett, W. C.; Stampfer, M. J. Blood donations and risk of coronary heart disease in men. Circulation 103:52-57; 2001.
34. Nitenberg, A.; Paycha, F.; Ledoux, S.; Sachs, R.; Attali, J. R.; Valensi, P. Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation 97:736-743; 1998.
35. Hattori, N.; Rihl, J.; Bengel, F. M.; Nekolla, S. G.; Standl, E.; Schwaiger, M.; Schnell, O. Cardiac autonomic dysinnervation and myocardial blood flow in long-term Type 1 diabetic patients. Diabet. Med. 20:375-381; 2003.
36. Duffy, S. J.; Biegelsen, E. S.; Holbrook, M.; Russell, J. D.; Gokce, N.; Keaney, J. F. Jr.; Vita, J. A. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 103:2799-2804; 2001.
37. Minqin, R.; Rajendran, R.; Pan, Ning; Kwong-Huat Tan, B.; Ong, W. Y.; Watt, F.; Halliwell, B. The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit. Free Radic. Biol. Med. 38:1206-1211; 2005.
38. Juckett, M. B.; Balla, J.; Balla, G.; Jessurun, J.; Jacob, H. S.; Vercellotti, G. M. Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am. J. Pathol. 147:782-789; 1995.
39. Pourzand, C.; Watkin, R. D.; Brown, J. E.; Tyrrell, R. M. Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: the role of ferritin. Proc. Natl. Acad. Sci. USA 96:6751-6756; 1999.
40. Orino, K.; Lehman, L.; Tsuji, Y.; Ayaki, H.; Torti, S. V.; Torti, F. M. Ferritin and the response to oxidative stress. Biochem. J. 357:241-247; 2001.
41. Jang, M. K.; Choi, M. S.; Park, Y B. Regulation of ferritin light chain gene expression by oxidized low-density lipoproteins in human monocytic THP-1 cells. Biochem. Biophys. Res. Commun. 265:577-583; 1999.
42. Chen, X. L.; Varner, S. E.; Rao, A. S.; Grey, J. Y.; Thomas, S.; Cook, C. K.; Wasserman, M. A.; Medford, R. M.; Jaiswal, A. K.; Kunsch, C. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells: a novel anti-inflammatory mechanism. J. Biol. Chem. 278:703-711; 2003.
43. Berberat, P. O.; Katori, M.; Kaczmarek, E.; Anselmo, D.; Lassman, C.; Ke, B.; Shen, X.; Busuttil, R. W.; Yamashita, K.; Csizmadia, E.; Tyagi, S.; Otterbein, L. E.; Brouard, S.; Tobiasch, E.; Bach, F. H.; Kupiec-Weglinski, J. W.; Soares, M. P. Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J. 17:1724-1726; 2003.
44. Garner, B.; Li, W.; Roberg, K.; Brunk, U. T. On the cytoprotective role of ferritin in macrophages and its ability to enhance lysosomal stability. Free Radic. Res. 27:487-500; 1997.
45. Reif, D. W. Ferritin as a source of iron for oxidative damage. Free Radic. Biol. Med. 12:417-427; 1992.
46. Steinberg, D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272:20963-20966; 1997.
47. Uemura, M.; Manabe, H.; Yoshida, N.; Fujita, N.; Ochiai, J.; Matsumoto, N.; Takagi, T.; Naito, Y.; Yoshikawa, T. Alphatocopherol prevents apoptosis of vascular endothelial cells via a mechanism exceeding that of mere antioxidation. Eur. J. Pharmacol. 456:29-37; 2002.
48. O'Callaghan, Y C.; Woods, J. A.; O'Brien, N. M. Characteristics of 7 beta-hydroxycholesterol-induced cell death in a human monocytic blood cell line, U937, and a human hepatoma cell line, HepG2. Toxicol. In Vitro 16:245-251; 2002.
49. Biasi, F.; Leonarduzzi, G.; Vizio, B.; Zanetti, D.; Sevanian, A.; Sottero, B.; Verde, V.; Zingaro, B.; Chiarpotto, E.; Poli, G. Oxysterol mixtures prevent proapoptotic effects of 7-ketocholesterol in macrophages: implications for proatherogenic gene modulation. FASEB J. 18:693-695; 2004.
50. Kurz, T.; Leake, A.; Zglincki, T. V.; Brunk, U. T. Relocalized redox-active lysosomal iron is an important mediator of oxidative stress-induced DNA damage. Biochem. J. 378:1039-1045; 2004.
51. Tenopoulou, M.; Doulias, P. T.; Barbouti, A.; Brunk, U. T.; Galaris, D. The role of compartmentalized redox-active iron on oxidative stress-induced DNA damage and apoptosis. Biochem. J. 387; 2005.